Functionally, the AKT1 E17K mutation stimulates AKT signalling, induces cellular transformation and produces leukaemia in mice, strongly suggesting that this mutation may play a crucial role in cancer development (Carpten et al, 2007). This evidence concerns the gene AKT1 and leukemia.